The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease

被引:164
|
作者
Cheng, Ying [1 ]
Bai, Feng [2 ]
机构
[1] Southeast Univ, Sch Med, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China
来源
FRONTIERS IN NEUROSCIENCE | 2018年 / 12卷
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; tau; mitochondrial transport; mitochondrial dynamics; mitochondrial dysfunction; AXONAL-TRANSPORT DEFECTS; OXIDATIVE STRESS; PHOSPHORYLATED TAU; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; HYPERPHOSPHORYLATED TAU; SYNAPTIC DYSFUNCTION; ABNORMAL INTERACTION; MOUSE MODEL; PROTEIN-TAU;
D O I
10.3389/fnins.2018.00163
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence suggests that abnormally hyperphosphorylated tau plays a vital role in the pathogenesis of Alzheimer's disease (AD). Mitochondrial dysfunction also has a recognized role in the pathophysiology of AD. In recent years, mitochondrial dysfunction has been strongly associated with tau pathology in AD. Overexpression of hyperphosphorylated and aggregated tau appears to damage the axonal transport, leading to abnormal mitochondrial distribution. In addition, pathological tau impairs mitochondrial dynamics by regulating mitochondrial fission/fusion proteins, and further causes mitochondrial dysfunction and neuronal damage. Moreover, mitochondrial dysfunction is also involved in promoting tau pathology in AD. In this article, we evaluate the relationship between phosphorylated tau and mitochondrial dysfunction in AD.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] The role of pathological tau in synaptic dysfunction in Alzheimer's diseases
    Wu, Moxin
    Zhang, Manqing
    Yin, Xiaoping
    Chen, Kai
    Hu, Zhijian
    Zhou, Qin
    Cao, Xianming
    Chen, Zhiying
    Liu, Dan
    TRANSLATIONAL NEURODEGENERATION, 2021, 10 (01)
  • [12] Mitochondrial dysfunction in neocortex and hippocampus of olfactory bulbectomized mice, a model of Alzheimer's disease
    Avetisyan, A. V.
    Samokhin, A. N.
    Alexandrova, I. Y.
    Zinovkin, R. A.
    Simonyan, R. A.
    Bobkova, N. V.
    BIOCHEMISTRY-MOSCOW, 2016, 81 (06) : 615 - 623
  • [13] Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease
    Reddy, P. Hemachandra
    BRAIN RESEARCH, 2011, 1415 : 136 - 148
  • [14] Pathological Impact of Tau Proteolytical Process on Neuronal and Mitochondrial Function: a Crucial Role in Alzheimer's Disease
    Olesen, Margrethe A.
    Quintanilla, Rodrigo A.
    MOLECULAR NEUROBIOLOGY, 2023, 60 (10) : 5691 - 5707
  • [15] Mitochondrial dysfunction in Alzheimer's disease
    D'Alessandro, Maria Clara Bila
    Kanaan, Salim
    Geller, Mauro
    Pratico, Domenico
    Daher, Joao Paulo Lima
    AGEING RESEARCH REVIEWS, 2025, 107
  • [16] Data-driven modeling of mitochondrial dysfunction in Alzheimer's disease
    Toglia, Patrick
    Demuro, Angelo
    Mak, Don-On Daniel
    Ullah, Ghanim
    CELL CALCIUM, 2018, 76 : 23 - 35
  • [17] Mitochondrial dysfunction and Alzheimer's disease
    Maruszak, Aleksandra
    Zekanowski, Cezary
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02) : 320 - 330
  • [18] Microglia in Alzheimer's Disease in the Context of Tau Pathology
    Perea, Juan Ramon
    Bolos, Marta
    Avila, Jesus
    BIOMOLECULES, 2020, 10 (10) : 1 - 26
  • [19] The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis
    Ashleigh, Theophania
    Swerdlow, Russell H.
    Beal, M. Flint
    ALZHEIMERS & DEMENTIA, 2023, 19 (01) : 333 - 342
  • [20] Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease
    Cabezas-Opazo, Fabian A.
    Vergara-Pulgar, Katiana
    Jose Perez, Maria
    Jara, Claudia
    Osorio-Fuentealba, Cesar
    Quintanilla, Rodrigo A.
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015, 2015